These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 38758632

  • 1. Population Pharmacokinetic Modeling of Unbound Meropenem in Patients Undergoing Continuous Renal Replacement Therapy: An Observational Cohort Study.
    Oda K, Jono H, Kamohara H, Saito H.
    Ther Drug Monit; 2024 Oct 01; 46(5):584-593. PubMed ID: 38758632
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Population Pharmacokinetic Meta-Analysis and Dosing Recommendation for Meropenem in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.
    Peng Y, Cheng Z, Xie F.
    Antimicrob Agents Chemother; 2022 Sep 20; 66(9):e0082222. PubMed ID: 36005753
    [Abstract] [Full Text] [Related]

  • 5. Optimal Meropenem Dosing Regimens in Patients Undergoing Continuous Renal Replacement Therapy: Systematic Review and Monte Carlo Simulations.
    Charoensareerat T, Chaijamorn W, Kerdnimith P, Kosumwisaisakul N, Teeranaew P, Rungkitwattanakul D, Boonpeng A, Srisawat N, Pattharachayakul S.
    Blood Purif; 2023 Sep 20; 52(6):503-515. PubMed ID: 37231811
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Meropenem population pharmacokinetics in critically ill patients with septic shock and continuous renal replacement therapy: influence of residual diuresis on dose requirements.
    Ulldemolins M, Soy D, Llaurado-Serra M, Vaquer S, Castro P, Rodríguez AH, Pontes C, Calvo G, Torres A, Martín-Loeches I.
    Antimicrob Agents Chemother; 2015 Sep 20; 59(9):5520-8. PubMed ID: 26124172
    [Abstract] [Full Text] [Related]

  • 9. Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Patients: How to Achieve Best Dosage Regimen According to the Clinical Situation.
    O'Jeanson A, Larcher R, Le Souder C, Djebli N, Khier S.
    Eur J Drug Metab Pharmacokinet; 2021 Sep 20; 46(5):695-705. PubMed ID: 34403127
    [Abstract] [Full Text] [Related]

  • 10. Population pharmacokinetics of standard-dose meropenem in critically ill patients on continuous renal replacement therapy: a prospective observational trial.
    Onichimowski D, Będźkowska A, Ziółkowski H, Jaroszewski J, Borys M, Czuczwar M, Wiczling P.
    Pharmacol Rep; 2020 Jun 20; 72(3):719-729. PubMed ID: 32301057
    [Abstract] [Full Text] [Related]

  • 11. Effect of renal clearance and continuous renal replacement therapy on appropriateness of recommended meropenem dosing regimens in critically ill patients with susceptible life-threatening infections.
    Burger R, Guidi M, Calpini V, Lamoth F, Decosterd L, Robatel C, Buclin T, Csajka C, Marchetti O.
    J Antimicrob Chemother; 2018 Dec 01; 73(12):3413-3422. PubMed ID: 30304491
    [Abstract] [Full Text] [Related]

  • 12. Optimal Dosing of Meropenem in a Small Cohort of Critically Ill Children Receiving Continuous Renal Replacement Therapy.
    Tan WW, Watt KM, Boakye-Agyeman F, Cohen-Wolkowiez M, Mok YH, Yung CF, Chan YH.
    J Clin Pharmacol; 2021 Jun 01; 61(6):744-754. PubMed ID: 33314163
    [Abstract] [Full Text] [Related]

  • 13. Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.
    Schatz LM, Brinkmann A, Röhr A, Frey O, Greppmair S, Weinelt F, Zoller M, Scharf C, Hempel G, Liebchen U.
    Antimicrob Agents Chemother; 2023 May 17; 67(5):e0010423. PubMed ID: 37125925
    [Abstract] [Full Text] [Related]

  • 14. Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients.
    Busse D, Simon P, Schmitt L, Petroff D, Dorn C, Dietrich A, Zeitlinger M, Huisinga W, Michelet R, Wrigge H, Kloft C.
    Clin Pharmacokinet; 2022 May 17; 61(5):655-672. PubMed ID: 34894344
    [Abstract] [Full Text] [Related]

  • 15. Meropenem pharmacokinetic/pharmacodynamic target attainment and clinical response in ICU patients: A prospective observational study.
    Helset E, Cheng V, Sporsem H, Thorstensen C, Nordøy I, Gammelsrud KW, Hanssen G, Ponzi E, Lipman J, von der Lippe E.
    Acta Anaesthesiol Scand; 2024 Apr 17; 68(4):502-511. PubMed ID: 38286568
    [Abstract] [Full Text] [Related]

  • 16. Population Pharmacokinetics and Dosing Optimization of Gentamicin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.
    He S, Cheng Z, Xie F.
    Drug Des Devel Ther; 2022 Apr 17; 16():13-22. PubMed ID: 35023902
    [Abstract] [Full Text] [Related]

  • 17. The effect of a loading dose of meropenem on outcomes of patients with sepsis treated by continuous renal replacement: study protocol for a randomized controlled trial.
    Ni SQ, Teng WB, Fu YH, Su W, Yang Z, Cai J, Xu JN, Deng XY, Liu XF, Fu SN, Zeng J, Zhang C.
    Trials; 2022 Apr 12; 23(1):294. PubMed ID: 35413886
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.